Drug intelligence / Profile preview

oxycodone + fentanyl

Development stage
Phase 4
Lead developer
Merck
Modality
Small Molecules
Administration
Oral, Intravenous, Transdermal, Intramuscular, Sublingual, Buccal, Intranasal, Epidural, Intrathecal
01

Overview

Oxycodone and fentanyl are both potent opioid analgesics used for pain management. When combined, they represent a powerful pain management approach, though this specific combination is not typically prescribed as a single formulation. **Oxycodone** is a semi-synthetic opioid analgesic that acts on mu-, kappa-, and delta-type opioid receptors. It is approximately 1.5 times more potent than oral morphine and is used for moderate to severe pain. It is available in immediate-release and extended-release formulations. **Fentanyl** is a synthetic opioid that is approximately 100 times more potent than morphine and 50 times more potent than heroin. It is FDA-approved for use as an analgesic and anesthetic, primarily used for severe pain management, including cancer pain and post-surgical pain. Both medications can cause respiratory depression, sedation, euphoria, and have high potential for dependence and abuse.

Other names
ApaceChina GirlChina TownDance FeverFriendGoodfellasGreat BearHe-ManJackpotKing IvoryMurder 8Murder8Murder-8PoisonTango & CashHillbilly HeroinKickerOCOxRoxy
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on oxycodone + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxycodone + fentanyl.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call